Drp1 is dispensable for apoptotic cytochrome c release in primed MCF10A and fibroblast cells but affects Bcl-2 antagonist-induced respiratory changes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 00071188 AND DT 2014 AND VI 171 AND IP 8
Results: 32
1
2
Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2099, doi. 10.1111/bph.12369
- By:
- Publication type:
- Article
4
Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2080, doi. 10.1111/bph.12475
- By:
- Publication type:
- Article
5
Lipid analogues as potential drugs for the regulation of mitochondrial cell death.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2051, doi. 10.1111/bph.12417
- By:
- Publication type:
- Article
6
Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2017, doi. 10.1111/bph.12468
- By:
- Publication type:
- Article
7
Bioenergetic medicine.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1854, doi. 10.1111/bph.12394
- By:
- Publication type:
- Article
8
Mitochondrial function and energy metabolism in neuronal HT22 cells resistant to oxidative stress.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2147, doi. 10.1111/bph.12549
- By:
- Publication type:
- Article
9
Mitochondrial protein quality control in health and disease.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1870, doi. 10.1111/bph.12430
- By:
- Publication type:
- Article
10
Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2174, doi. 10.1111/bph.12470
- By:
- Publication type:
- Article
11
Drp1 is dispensable for apoptotic cytochrome c release in primed MCF10 A and fibroblast cells but affects Bcl-2 antagonist-induced respiratory changes.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1988, doi. 10.1111/bph.12515
- By:
- Publication type:
- Article
12
Mitochondrially targeted nitro-linoleate: a new tool for the study of cardioprotection.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2091, doi. 10.1111/bph.12405
- By:
- Publication type:
- Article
13
Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2000, doi. 10.1111/bph.12416
- By:
- Publication type:
- Article
14
Development of pharmacological strategies for mitochondrial disorders.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1798, doi. 10.1111/bph.12456
- By:
- Publication type:
- Article
15
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2123, doi. 10.1111/bph.12368
- By:
- Publication type:
- Article
16
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1917, doi. 10.1111/bph.12503
- By:
- Publication type:
- Article
17
Mitochondrial pharmacology: energy, injury and beyond.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
18
Unravelling mitochondrial pathways to Parkinson's disease.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1943, doi. 10.1111/bph.12433
- By:
- Publication type:
- Article
19
Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2067, doi. 10.1111/bph.12363
- By:
- Publication type:
- Article
20
Autophagy and mitophagy in the myocardium: therapeutic potential and concerns.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1907, doi. 10.1111/bph.12477
- By:
- Publication type:
- Article
21
Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: How important is BDNF?
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2206, doi. 10.1111/bph.12531
- By:
- Publication type:
- Article
22
Mitochondrial metals as a potential therapeutic target in neurodegeneration.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2159, doi. 10.1111/bph.12513
- By:
- Publication type:
- Article
23
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2029, doi. 10.1111/bph.12461
- By:
- Publication type:
- Article
24
A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2230, doi. 10.1111/bph.12494
- By:
- Publication type:
- Article
25
Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2191, doi. 10.1111/bph.12476
- By:
- Publication type:
- Article
26
Next-generation sequencing for mitochondrial disorders.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1837, doi. 10.1111/bph.12469
- By:
- Publication type:
- Article
27
Issue Information.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. i, doi. 10.1111/bph.12377
- Publication type:
- Article
28
Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 2243, doi. 10.1111/bph.12570
- By:
- Publication type:
- Article
29
Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1973, doi. 10.1111/bph.12431
- By:
- Publication type:
- Article
30
Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1890, doi. 10.1111/bph.12516
- By:
- Publication type:
- Article
31
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1818, doi. 10.1111/bph.12413
- By:
- Publication type:
- Article
32
Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 8, p. 1958, doi. 10.1111/bph.12453
- By:
- Publication type:
- Article